Cargando…

Aggressive NK Cell Leukemia: Current State of the Art

SIMPLE SUMMARY: Aggressive natural killer cell leukemia (ANKL) is a rare, lethal disease that presents many diagnostic and therapeutic challenges. Recent studies have shed new light on the salient features of its molecular pathogenesis and provided further insight into the clinicopathologic spectrum...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Hussein, Siba, Medeiros, L. Jeffrey, Khoury, Joseph D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600035/ https://www.ncbi.nlm.nih.gov/pubmed/33050313 http://dx.doi.org/10.3390/cancers12102900

Ejemplares similares

Aggressive NK-Cell Leukemia
por: Ishida, Fumihiro
Publicado: (2018)

Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes
por: Tang, Y-T, et al.
Publicado: (2017)

Current state of NK cell-mediated immunotherapy in chronic lymphocytic leukemia
por: Wang, Zong-Han, et al.
Publicado: (2023)

Chronic Lymphocytic Leukemia Progression Diagnosis with Intrinsic Cellular Patterns via Unsupervised Clustering
por: Chen, Pingjun, et al.
Publicado: (2022)

Non-EBV-Related Aggressive NK-Cell Leukemia: An Oncohematological Great Imitator
por: Lepe-Zuniga, Jose L., et al.
Publicado: (2018)

Systemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and Update
por: El Hussein, Siba, et al.
Publicado: (2022)

Treatment of Aggressive NK-Cell Leukemia: A Case Report and Review of the Literature
por: Boysen, Anders Kindberg, et al.
Publicado: (2011)

Clinical management of achalasia: current state of the art
por: Krill, Joseph T, et al.
Publicado: (2016)

Vertebral Augmentation: State of the Art
por: Sebaaly, Amer, et al.
Publicado: (2016)

Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm
por: Wang, Wei, et al.
Publicado: (2022)

T cells, NK cells, and tumor-associated macrophages in cancer immunotherapy and the current state of the art of drug delivery systems
por: Yang, Ya-long, et al.
Publicado: (2023)

Pharmacogenomics: Current State-of-the-Art
por: Carr, Daniel F., et al.
Publicado: (2014)

Aggressive natural killer cell leukemia or extranodal NK/T cell lymphoma? a case with nasal involvement
por: Jin, Xiaoke, et al.
Publicado: (2017)

State-of-Art of Cellular Therapy for Acute Leukemia
por: Lee, Jong-Bok, et al.
Publicado: (2021)

Aggressive NK-cell leukemia in a 69 years old Caucasian woman: a case report
por: Matzen, Sara Maj Hyldig, et al.
Publicado: (2015)

Histamine Intolerance: The Current State of the Art
por: Comas-Basté, Oriol, et al.
Publicado: (2020)

Cancer Chemoprevention: Current State of the Art
por: Landis-Piwowar, Kristin R, et al.
Publicado: (2014)

Imaging of HCC—Current State of the Art
por: Schraml, Christina, et al.
Publicado: (2015)

Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art
por: Feola, Tiziana, et al.
Publicado: (2022)

NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications
por: Sportoletti, Paolo, et al.
Publicado: (2021)

CellSpatialGraph: Integrate hierarchical phenotyping and graph modeling to characterize spatial architecture in tumor microenvironment on digital pathology
por: Chen, Pingjun, et al.
Publicado: (2021)

State-of-the-art for CAR T-cell therapy for chronic lymphocytic leukemia in 2019
por: Lemal, Richard, et al.
Publicado: (2019)

Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation
por: Barilà, Gregorio, et al.
Publicado: (2018)

Robotic Gastrectomy: The Current State of the Art
por: Marano, Alessandra, et al.
Publicado: (2012)

Modulators for Terahertz Communication: The Current State of the Art
por: Ma, Z. T., et al.
Publicado: (2019)

Minimally invasive veneers: current state of the art
por: Vanlıoğlu, Burçin Akoğlu, et al.
Publicado: (2014)

Current animal models of hemophilia: the state of the art
por: Yen, Ching-Tzu, et al.
Publicado: (2016)

Diabetes and aortic aneurysm: current state of the art
por: Raffort, Juliette, et al.
Publicado: (2018)

Proton Therapy For Lymphomas: Current State Of The Art
por: Ricardi, Umberto, et al.
Publicado: (2019)

Psoriasis and Gut Microbiome—Current State of Art
por: Polak, Karina, et al.
Publicado: (2021)

Materials for Dentoalveolar Bioprinting: Current State of the Art
por: Salar Amoli, Mehdi, et al.
Publicado: (2021)

Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic Leukemia
por: Hofland, Tom, et al.
Publicado: (2019)

Potential Biomarkers for Treatment Response to the BCL-2 Inhibitor Venetoclax: State of the Art and Future Directions
por: Salah, Haneen T., et al.
Publicado: (2021)

Intravascular NK/T-Cell Lymphoma: What We Know about This Diagnostically Challenging, Aggressive Disease
por: Zanelli, Magda, et al.
Publicado: (2022)

Stem Cells Regenerating the Craniofacial Skeleton: Current State-Of-The-Art and Future Directions
por: Oliver, Jeremie D., et al.
Publicado: (2020)

Hybrid/Atypical Forms of Circulating Tumor Cells: Current State of the Art
por: Kaigorodova, Evgeniya V., et al.
Publicado: (2022)

Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse
por: Samra, Bachar, et al.
Publicado: (2021)

Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases
por: Fang, Hong, et al.
Publicado: (2022)

Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art
por: Lebastchi, Amir H., et al.
Publicado: (2012)

Nanoimaging in cardiovascular diseases: Current state of the art
por: Deb, Suryyani, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_itnki5b3bjv7se4oist1mh1jd6